Laurel T. Bate-Eya - Concepedia

Author

Laurel T. Bate-Eya

University of Amsterdam

Also Known As

Laurel Bate-Eya, Laurel T. Bate-Eya, Laurel Tabe Bate-Eya, Laurel Tabe Bate‐Eya

Publications

608

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Emma Kinderziekenhuis University of Turku Åbo Akademi University

About

Laurel T. Bate-Eya is an author at University of Amsterdam specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	312
2	Cell Biology	3	3	129
3	Engineering	1	1	183
4	Biomedical Engineering	1	1	183
5	Molecular Biology	1	1	27

Laurel T. Bate-Eya

Publications

606

Citations

H-Index

Page 1

	Year	Citations
Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer Veronika Mamaeva, Jessica M. Rosenholm, Laurel T. Bate-Eya, Molecular Therapy	2011	216
Cancer‐Cell‐Specific Induction of Apoptosis Using Mesoporous Silica Nanoparticles as Drug‐Delivery Vectors Jessica M. Rosenholm, Emilia Peuhu, Laurel T. Bate-Eya, Small NanoparticlesEngineeringCancer‐cell‐specific InductionBiomedical EngineeringSelective Apoptosis	2010	183
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours Laurel T. Bate-Eya, Marli E. Ebus, Jan Köster, European Journal of Cancer Tumor BiologyPrimary Neuroblastoma TumoursTumor InnervationPathologyNeuroblasts	2013	67
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition Laurel T. Bate-Eya, Ilona J.M. den Hartog, Ida van der Ploeg, Oncotarget	2016	60
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity Laurel T. Bate-Eya, Hinco J. Gierman, Marli E. Ebus, European Journal of Cancer ChromatinDevelopmental BiologyChromatin RemodelingEpigenetic ChangeEpigenomics	2017	35
DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells M. Emmy M. Dolman, Ida van der Ploeg, Jan Köster, PLoS ONE Radiation MedicineCell RegulationRadiation TherapyRadiation BiologyMolecular Target	2015	27
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells Lindy Vernooij, Laurel T. Bate-Eya, Lindy K. Alles, Molecular Cancer Therapeutics	2021	18

Page 1